Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Pain and Therapy
Published in: Pain and Therapy 1/2019

Open Access 01-06-2019 | Opioids | Letter

CBD as the New Medicine in the Pain Provider’s Armamentarium

Authors: Charlie Piermarini, Omar Viswanath

Published in: Pain and Therapy | Issue 1/2019

Login to get access

Excerpt

Following the recent publication “An Update of Current Cannabis-based Pharmaceuticals in Pain Medicine,” [1] we felt compelled to highlight and expound upon an important point mentioned in the review. As providers who currently treat some chronic pain patients with CBD oil as part of a multimodal analgesic treatment regimen, we have found great benefit of this new weapon recently being utilized in our armamentarium. As mentioned in the article, the current political climate surrounding CBD is both vague and ever-changing, which can and does impact treatment and subsequent patient outcomes as pain medicine providers. …
Literature
1.
2.
Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling accuracy of cannabidiol extracts sold online. JAMA. 2017;318(17):1708–9.CrossRef
Metadata
Title
CBD as the New Medicine in the Pain Provider’s Armamentarium
Authors
Charlie Piermarini
Omar Viswanath
Publication date
01-06-2019
Publisher
Springer Healthcare
Keywords
Opioids
Opioids
Published in
Pain and Therapy / Issue 1/2019
Print ISSN: 2193-8237
Electronic ISSN: 2193-651X
DOI
https://doi.org/10.1007/s40122-019-0117-1

Other articles of this Issue 1/2019

Pain and Therapy 1/2019 Go to the issue

Commentary

When the Best of Intentions Leads to Bad Outcomes

Brief Report

A Novel Application of an Adjustable Catheter in Acute Radicular Pain Management

Case Report

Poppy Seed Tea: A Short Review and Case Study

Original Research

Clinical Results and Complications of Shoulder Manipulation under Ultrasound-Guided Cervical Nerve Root Block for Frozen Shoulder: A Retrospective Observational Study

Correction

Correction to: Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer

Review

Intravenous Oxycodone Versus Other Intravenous Strong Opioids for Acute Postoperative Pain Control: A Systematic Review of Randomized Controlled Trials

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits